CSL stock falls below $200 by July 2026

CSL's announced impairments and profit outlook cut signal weaker near-term financials. Given historical sensitivity to plasma supply dynamics, the stock is likely to breach the $200 threshold as investors reassess growth prospects.

Implied probability (Yes)

75%